Tetrabenazine Tablet
Product Images NDC 60505-3883

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 60505-3883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

A line graph showing chorea score change over study weeks comparing placebo (dashed line) and tetrabenazine (solid line). The x-axis represents the study weeks from -1 to 14, and the y-axis shows the chorea score change. Data points include error bars indicating variability. The graph also notes the sample sizes for each group per week and a washout period around week 13.*

FDA Label Image

Figure2.jpg (Figure2)

A line graph comparing the change from baseline in chorea scores between tetrabenazine and placebo treatment groups. The x-axis represents the change in chorea score, while the y-axis shows the percentage of patients. The graph includes vertical lines marking 10, 6, and 3-point changes and a table summarizing the percentage of patients achieving various ranges of chorea score changes for each group.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of tetrabenazine, showing its molecular skeleton with distinct functional groups including methoxy (CH3O) substituents and a ketone group, consistent with its pharmaceutical identity.*

FDA Label Image

Btl-lbl-12.5mg-112s.jpg (Btl Lbl 12.5mg 112s)

Label for Tetrabenazine Tablets 12.5 mg by Apotex Corp. The label indicates a package containing 112 oral tablets. Storage instructions specify keeping the product at 20° to 25°C (68° to 77°F). The label includes the National Drug Code (NDC) 60505-3882-7 and manufacturer information for Apotex Inc., Toronto, Ontario, and Apotex Corp., Weston, Florida.*

FDA Label Image

Btl-lbl-25mg-112s.jpg (Btl Lbl 25mg 112s)

Label for Tetrabenazine Tablets 25 mg by Apotex Corp. The label states the package contains 112 tablets. It includes storage instructions (20° to 25°C), dispensing directions, a pharmacist note about the Medication Guide, and manufacturer information. A barcode and NDC 60505-3883-7 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.